The ROE as of December 2024 (TTM) for Recursion Pharmaceuticals, Inc. (RXRX) is -76.53%

According to Recursion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -76.53%. This represents a change of 293.59% compared to the average of -19.44% of the last 4 quarters.

Recursion Pharmaceuticals, Inc. (RXRX) Historical ROE (quarterly & annually)

How has RXRX ROE performed in the past?

The mean historical ROE of Recursion Pharmaceuticals, Inc. over the last ten years is -11.99%. The current -76.53% ROE has changed 538.21% with respect to the historical average. Over the past ten years (40 quarters), RXRX's ROE was at its highest in in the March 2021 quarter at 13.18%. The ROE was at its lowest in in the March 2020 quarter at -23.98%.

Recursion Pharmaceuticals, Inc. (RXRX) ROE by Quarter and Year

Discovering the peaks and valleys of Recursion Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Recursion Pharmaceuticals, Inc. (RXRX) Average ROE

How has RXRX ROE performed in the past?

The current ROE of Recursion Pharmaceuticals, Inc. (RXRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Recursion Pharmaceuticals, Inc. (RXRX) ROE vs. Peers

How is RXRX’s ROE compared to its peers?

Recursion Pharmaceuticals, Inc.’s ROE is greater than Absci Corporation (-46.56%), greater than Affimed N.V. (-193.85%), greater than Sana Biotechnology, Inc. (-94.47%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Immix Biopharma, Inc. (-102.10%), less than CNS Pharmaceuticals, Inc. (695.91%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), greater than Freeline Therapeutics Holdings plc (-77.99%), less than AVROBIO, Inc. (29.68%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Enveric Biosciences, Inc. (-201.01%), greater than CohBar, Inc. (-58.44%), less than Ocean Biomedical, Inc. (42.06%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Inozyme Pharma, Inc. (-88.42%), greater than VectivBio Holding AG (-56.92%),

Build a custom stock screener for Recursion Pharmaceuticals, Inc. (RXRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recursion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recursion Pharmaceuticals, Inc. (RXRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recursion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.